PARD Stock Price Chart
PARD Earnings
Poniard Pharmaceuticals Inc
$0
0%
$0
At close: May 08, 16:00:00 GMT-4
$0
0%
$0
Post-market: May 08, 20:00:00 GMT-4
Back
Poniard Pharmaceuticals Inc (PARD) Earnings
Key Stats
Prev.Close
$0
Open
$0.0001
Day's Range
$0 - $0.0001
52 week range
$0 - $0.0001
Volume
7
Avg.Volume
60
Dividend yield
--
EPS (TTM)
-11.78
Market Cap
$15.000000000000002
What is PARD?
Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
